Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-C motif chemokine receptor 10 is a protein encoded by the CCR10 gene, classified as a class A G protein-coupled receptor that binds chemokines CCL27 and CCL28[1][2][5][7]. It is primarily expressed by melanocytes, plasma cells, and skin-homing T cells, playing a key role in regulating immune cell migration to the skin and inflamed tissues. CCR10 is implicated in skin immunity, inflammatory diseases, and cancer processes, particularly mediating cutaneous T cell responses and metastasis of melanoma to lymph nodes[1]. The receptor is widely recognized as a therapeutic target in immunology and oncology research, with experimental antagonists shown to reduce inflammatory responses in preclinical models[2].
Inhibition of chemokine binding (CCL27, CCL28) to CCR10\nReduction of immune cell migration and inflammatory response
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-C motif chemokine receptor 10 (CCR10).